用于不确定甲状腺结节的10基因分类器:开发与多中心准确性研究
研究分两阶段开发用于不确定甲状腺细胞学的10基因体外诊断分类器:先以114例新鲜组织活检的18基因qPCR表达数据训练分类器,在139例独立样本中验证;再将最佳分类器转为多重qPCR体外诊断原型,在前瞻性多中心细针穿刺活检队列中测试,曲线下面积0.97,阳性预测值78%,阴性预测值98%。
要点
- 组织活检中10基因分类器交叉验证测试集敏感度93%、特异度81%。
- 多中心细针穿刺队列中原型曲线下面积0.97,阳性预测值78%,阴性预测值98%。
- 贝叶斯定理预期在癌症患病率20-40%时阳性预测值64-82%、阴性预测值97-99%。
核心结论
- 报告了一种新的多重qPCR体外诊断原型,可准确分类甲状腺结节,并可能为本地参考实验室检测提供未来解决方案。
研究设计与样本
- 第一阶段用定量聚合酶链反应(qPCR)在114例新鲜组织活检的广泛组织病理学谱中测定18个基因表达,并以监督机器学习方法训练多个分类器,在139例独立样本中测试。
- 第二阶段选择最佳分类器作为模型开发多重qPCR体外诊断原型,并在前瞻性多中心细针穿刺活检队列中测试。
主要发现
- 在组织活检中,仅使用10个基因的最佳分类器在九倍交叉验证测试集中达到敏感度93%和特异度81%。
- 在多中心细针穿刺活检样本队列中,构建为多重qPCR体外诊断原型的10基因特征显示曲线下面积0.97、阳性预测值78%、阴性预测值98%。
- 按贝叶斯定理,在癌症患病率20-40%的患者中,该体外诊断原型预期达到阳性预测值64-82%和阴性预测值97-99%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In most of the world, diagnostic surgery remains the most frequent approach for indeterminate thyroid cytology. Although several molecular tests are available for testing in centralized commercial laboratories in the United States, there are no available kits for local laboratory testing. The aim of this study was to develop a prototype in vitro diagnostic (IVD) gene classifier for the further characterization of nodules with an indeterminate thyroid cytology. METHODS: In a first stage, the expression of 18 genes was determined by quantitative polymerase chain reaction (qPCR) in a broad histopathological spectrum of 114 fresh-tissue biopsies. Expression data were used to train several classifiers by supervised machine learning approaches. Classifiers were tested in an independent set of 139 samples. In a second stage, the best classifier was chosen as a model to develop a multiplexed-qPCR IVD prototype assay, which was tested in a prospective multicenter cohort of fine-needle aspiration biopsies. RESULTS: In tissue biopsies, the best classifier, using only 10 genes, reached an optimal and consistent performance in the ninefold cross-validated testing set (sensitivity 93% and specificity 81%). In the multicenter cohort of fine-needle aspiration biopsy samples, the 10-gene signature, built into a multiplexed-qPCR IVD prototype, showed an area under the curve of 0.97, a positive predictive value of 78%, and a negative predictive value of 98%. By Bayes' theorem, the IVD prototype is expected to achieve a positive predictive value of 64-82% and a negative predictive value of 97-99% in patients with a cancer prevalence range of 20-40%. CONCLUSIONS: A new multiplexed-qPCR IVD prototype is reported that accurately classifies thyroid nodules and may provide a future solution suitable for local reference laboratory testing.
引用
- González HE, Martínez JR, Vargas-Salas S, et al. A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study. Thyroid. 2017. PMID: 28521616. doi:10.1089/thy.2017.0067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。